Bayer loses three-year Australian pharmaceutical patent clash against Sandoz
A bitter clash between Bayer Intellectual Property and Swiss Pharmaceutical giant Sandoz AG over pharmaceutical patents has reached the end of the line in Australia, with the country’s supreme federal court...To view the full article, register now.
Already a subscriber? Click here to view full article